News Highlights

June 24, 2008
Concert Pharmaceuticals Named One of the “Fierce 15" Biotech Companies of 2008

April 30 , 2008
Concert Pharmaceuticals Raises $37 Million in Series C Financing

April 16 , 2008
Concert Pharmaceuticals Announces Appointment of Justine Koenigsberg as Senior Director, Corporate Communications and Investor Relations

March 11, 2008
Concert Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference

January 2, 2008
Concert Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference

Concert Pharmaceuticals uses selective deuterium modification to create important new products by improving validated, marketed and clinically proven drugs.